-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Rapport Therapeutics, Inc. quarterly Depreciation history and growth rate for Q2 2024.
- Rapport Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $200K.